PriceList for 2-Bromo-4-Benzyloxy-3-nitroacetophenone - 2′,3′-Di-O-acetyl-5′-deoxy-5-fluorocytidine CAS 161599-46-8 Purity ≥99.0% Capecitabine Intermediate Factory – Ruifu

Short Description:

Product Detail

Product Tags

Feedback (2)

Fast and superior quotations, informed advisers to help you choose the correct merchandise that suits all your requirements, a short generation time, responsible quality control and different services for paying and shipping affairs for Afatinib intermediates, 334618-23-4, CAS 173140-90-4, Should you be interested in almost any goods, remember to truly feel totally free to get in touch with us for further facts or be sure to deliver us email right, we will reply you in just 24 hrs as well as the finest quotation are going to be provided.

PriceList for 2-Bromo-4-Benzyloxy-3-nitroacetophenone - 2′,3′-Di-O-acetyl-5′-deoxy-5-fluorocytidine CAS 161599-46-8 Purity ≥99.0% Capecitabine Intermediate Factory – Ruifu Detail:

Commercial Supply Capecitabine Related Intermediates:
5-Fluorocytosine CAS: 2022-85-7
2′,3′-Di-O-acetyl-5′-deoxy-5-fluorocytidine CAS: 161599-46-8
1,2,3-Tri-O-acetyl-5-deoxy-β-D-ribofuranose CAS: 62211-93-2
Capecitabine CAS: 154361-50-9

Name	2′,3′-Di-O-acetyl-5′-deoxy-5-fluorocytidine
CAS Number	161599-46-8
CAT Number	RF-PI176
Stock Status	In Stock, Production Scale Up to Tons
Molecular Formula	C13H16FN3O6
Molecular Weight	329.28
Condition to Avoid	Heat Sensitive
Brand	Ruifu Chemical

Item	Specifications
Appearance	Whitish or Yellowish Crystalline Powder
Single Impurity	≤0.50%
Total Impurities	≤1.0%
Melting Point	178.0~193.0℃
Loss on Drying	≤0.50%
Residue on Ignition	≤0.10%
Moisture (K.F)	≤1.0%
Assay	≥99.0%
Purity / Analysis Method	≥99.0% (HPLC)
Test Standard	Enterprise Standard
Usage	Intermediate of Capecitabine (CAS: 154361-50-9)

Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer’s requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.

Capecitabine (CAS: 154361-50-9) is a new form of oral fluorinated pyrimidine drug. Capecitabine was developed by Roche Pharmaceuticals, and its commercial name is Xeloda. Capecitabine can change in vivo into 5- FU, an anti-metabolizim fluorine pyrimidine deoxynucleoside carbamate drug that targets cancer cells to inhibit cell division and disrupt RNA and protein synthesis. Its effects are significantly tied to the level of TP enzyme expression in neoplastic tissue and to DPD enzyme in vivo expression. It is suitable as further treatment for advanced primary or metastatic breast cancer patients who have not responded to paclitaxel or anthracycline antibiotics. As an anticancer drug, it is mostly used to treat advanced primary or metastatic breast cancer, as well as in treatment for non-small cell lung cancer, pancreatic cancer, bladder cancer, rectal cancer, colon cancer, gastric cancer, and other solid tumors.

Product detail pictures:

Related Product Guide:

It adheres for the tenet "Honest, industrious, enterprising, innovative" to develop new products and solutions continuously. It regards shoppers, success as its individual success. Let us produce prosperous future hand in hand for PriceList for 2-Bromo-4-Benzyloxy-3-nitroacetophenone - 2′,3′-Di-O-acetyl-5′-deoxy-5-fluorocytidine CAS 161599-46-8 Purity ≥99.0% Capecitabine Intermediate Factory – Ruifu , The product will supply to all over the world, such as: Guinea, Madrid, Slovakia, Over the years, with high-quality products, first- class service, ultra-low prices we win thee trust and favor of customers. Nowadays our products sell all over the domestic and abroad. Thanks for the regular and new customers support. We provide high quality product and competitive price, welcome the regular and new customers cooperate with us!